An interventional study of Alcohol administration in Heavy Episodic Drinking, sponsored by New York University. Recruiting at 1 site in United States. Open to participants aged 21 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by New York University · Not applicable, Interventional, and Other
Among 37 studies in Binge Drinking with a site in United States — 11 open to participants now, 13 under way, none of them phase 3. Binge Drinking · United States.
Among the 37 studies in Binge Drinking with a site in United States, this one is the 13th largest by planned enrollment of the 36 interventional ones, is one of 3 that started in 2025, is one of 31 with no phase, reaches primary completion later than 11 of the 12 other live ones, and was the 33rd registered.
71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.
This study's planned enrollment of 160 is above the median of 120 across 64 interventional studies indexed under Binge Drinking.
Browse Binge Drinking studies →11 of the 37 studies in Binge Drinking with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 16 Binge Drinking studies recruiting now, 3 (19%) set no upper age limit and 12 (75%) stop at 75 or younger; 2 take children under 18; 12 take healthy volunteers.
This study: 21 Years to 29 Years · all sexes · healthy volunteers too.
The full table on the hub →37 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 3 started in 2025.
Median enrollment 100 across the 36 interventional studies, 240 across the 1 observational. Of the 23 that completed or were terminated, 10 (43%) have results posted.
None of the 37 has an industry lead sponsor. The 10 most frequent:
New York University is the lead sponsor of 123 studies on the registry; 32 are open to participants now.
New York University has 1 study filed under Binge Drinking — fewer than ten, so there is no comparison to draw.
4 of the studies in Binge Drinking with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05522075The University of Texas at ArlingtonReducing Blood Pressure in Mid-life Adult Binge Drinkers | 2026-12-31 |
| NCT07125534University of Illinois at Urbana-ChampaignAlcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design | 2027-01 |
| NCT07418047University of Massachusetts, WorcesterPreliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults | 2027-01-31 |
| NCT06885190Rochester Institute of TechnologyMultisensory Processing of Alcohol Cues in Young Adult Binge Drinkers | 2027-08-15 |
Among the 37 studies in Binge Drinking with a site in United States, from their registry updates:
Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Although much is known about the influence of peers in EA alcohol use, there is a dearth of research examining the ways in which romantic partners influence EA drinking behaviors. The proposed study bridges a crucial gap in the existing literature by examining behavioral and physiological risk and resilience factors in the acute link between EA relationship conflict and alcohol consumption. EA couples will engage in two conflict resolution tasks interspersed with two puzzle tasks and two alcohol administration procedures. Because high frequency heart rate variability (HF-HRV) is associated with alcohol use and emotion regulation during stressful experiences, HF-HRV and other physiological data will be collected throughout the laboratory procedures.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This is the only arm of the study. All participants receive the alcohol administration intervention.
Other: Alcohol administration
In this study, participants complete two tasks, then are administered alcohol. Next, they repeat the tasks.
Alcohol consumption
Amount of alcohol consumed during the study
Time frame: ~20 minutes
High frequency heart rate variability (HF-HRV)
High frequency heart rate variability (HF-HRV) is a neurally-derived measure of parasympathetic activity that may partially explain the association between stressful relationship conflict and alcohol misuse. HF-HRV is a measure of the variability in interbeat intervals, or the time in between beats of the heart.
Time frame: ~3 hours
PDFs hosted by the registry, ClinicalTrials.gov.
Started Sep 2025 (actual). Primary completion is estimated for Jul 2028, 34 months after the start.
Of 38 interventional studies with no phase under Binge Drinking, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 49. This study's planned 34 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.